A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer

por Park, Y H, Kim, B-S, Ryoo, B-Y, Yang, S H
Publicado 2006

A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer

por Park, Y H, Ryoo, B-Y, Choi, S-J, Kim, H-T
Publicado 2004

Efficacy and safety of PAC‐14028 cream – a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild‐to‐moderate atopic dermatitis: a phase IIb randomized tria...

por Lee, Y.W., Won, C.‐H., Jung, K., Nam, H.‐J., Choi, G., Park, Y.‐H., Park, M., Kim, B.
Publicado 2019

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment

por Park, Y H, Jung, H A, Choi, M K, Chang, W, Choi, Y L, Do, I-g, Ahn, J S, Im, Y-H
Publicado 2014

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first...

por Lee, S, Park, Y H, Kim, K H, Cho, E Y, Ahn, Y C, Kim, K, Shim, Y-M, Ahn, J S, Park, K, Im, Y-H
Publicado 2010

Atmospheric drying as the main driver of dramatic glacier wastage in the southern Indian Ocean

por Favier, V., Verfaillie, D., Berthier, E., Menegoz, M., Jomelli, V., Kay, J. E., Ducret, L., Malbéteau, Y., Brunstein, D., Gallée, H., Park, Y.-H., Rinterknecht, V.
Publicado 2016

Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy

por Yun, J, Kim, K H, Kang, E S, Gwak, G-Y, Choi, M S, Lee, J E, Nam, S J, Yang, J-H, Park, Y H, Ahn, J S, Im, Y-H
Publicado 2011

The usefulness of modified national early warning score with the age level in critically ill medical patients

por Lee, YS, Lee, JW, Lee, J, Min, NE, Park, JE, Jung, JW, Park, DI, Kim, KD, Ahn, HJ, Choi, JW, Park, Y-H, Ryu, S, Jeong, WJ, Moon, JY
Publicado 2015

Establishment and characterisation of six human biliary tract cancer cell lines

por Ku, J-L, Yoon, K-A, Kim, I-J, Kim, W-H, Jang, J-Y, Suh, K-S, Kim, S-W, Park, Y-H, Hwang, J-H, Yoon, Y-B, Park, J-G
Publicado 2002

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

por Kwon, M J, Park, S, Choi, J Y, Oh, E, Kim, Y J, Park, Y-H, Cho, E Y, Kwon, M J, Nam, S J, Im, Y-H, Shin, Y K, Choi, Y-L
Publicado 2012

Nasal-type NK/T cell lymphoma: clinical features and treatment outcome

por Lee, J, Kim, W S, Park, Y H, Park, S H, Park, K W, Kang, J H, Lee, S S, Lee, S I, Lee, S-H, Kim, K, Jung, C W, Ahn, Y C, Ko, Y H, Park, K
Publicado 2005

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

por Park, Y H, Park, M J, Ji, S H, Yi, S Y, Lim, D H, Nam, D H, Lee, J-I, Park, W, Choi, D H, Huh, S J, Ahn, J S, Kang, W K, Park, K, Im, Y-H
Publicado 2009

Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from th...

por Cho, E.H., Kim, J.-Y., Im, S.-A., Jung, K.H., Sohn, J., Lee, K.S., Chae, Y.S., Lee, K.H., Kim, J.H., Jang, J.-H., Ahn, J.H., Park, M.S., Lee, S.-Y., Park, Y.H.
Publicado 2021

Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals

por Yun, H-M, Oh, J H, Shim, J-H, Ban, J O, Park, K-R, Kim, J-H, Lee, D H, Kang, J-W, Park, Y H, Yu, D, Kim, Y, Han, S B, Yoon, D-Y, Hong, J T
Publicado 2013

Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival

por Yap, Y S, Cornelio, G H, Devi, B C R, Khorprasert, C, Kim, S B, Kim, T Y, Lee, S C, Park, Y H, Sohn, J H, Sutandyo, N, Wong, D W Y, Kobayashi, M, Landis, S H, Yeoh, E M, Moon, H, Ro, J
Publicado 2012

IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals

por Oh, J H, Cho, M-C, Kim, J-H, Lee, S Y, Kim, H J, Park, E S, Ban, J O, Kang, J-W, Lee, D-H, Shim, J-H, Han, S B, Moon, D C, Park, Y H, Yu, D-Y, Kim, J-M, Kim, S H, Yoon, D-Y, Hong, J T
Publicado 2011

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

por Im, S.-A., Gennari, A., Park, Y.H., Kim, J.H., Jiang, Z.-F., Gupta, S., Fadjari, T.H., Tamura, K., Mastura, M.Y., Abesamis-Tiambeng, M.L.T., Lim, E.H., Lin, C.-H., Sookprasert, A., Parinyanitikul, N., Tseng, L.-M., Lee, S.-C., Caguioa, P., Singh, M., Naito, Y., Hukom, R.A., Smruti, B.K., Wang, S.-S., Kim, S.B., Lee, K.-H., Ahn, H.K., Peters, S., Kim, T.W., Yoshino, T., Pentheroudakis, G., Curigliano, G., Harbeck, N.
Publicado 2023